Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  American Journal of Physiology

• Publication date

  1973-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPLEGACY.1973.224.6.1450PMID 4712154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.

  1971cited by this paper
• Blood brain barrier permeability to lactate.

  1971cited by this paper
• Brain uptake of metabolites and drugs following carotid arterial injections.

  1971cited by this paper
• EVIDENCE FOR SEPARATE SYSTEMS FOR THE TRANSPORT OF NEUTRAL AND BASIC AMINO ACIDS ACROSS THE BLOOD‐BRAIN BARRIER

  1971cited by this paper
• Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard.

  1970cited by this paper
• RAPID PASSAGE OF ORGANIC ANIONS INTO HUMAN RED CELLS.

  1964cited by this paper
• Transfer of short‐chain fatty acids by the intestine

  1960cited by this paper
• Intestinal transfer of short‐chain fatty acids in vitro

  1958cited by this paper
• The relative rate of penetration of the lower saturated monocarboxylic acids into mammalian erythrocytes.

  1949cited by this paper
• The permeability of red blood corpuscles to organic anions

  1936cited by this paper

• Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma

  2026cites this paper
• Altered serum short-chain fatty acid profiles in episodic and chronic migraine and their modulation by preventive treatment

  2026cites this paper
• Developing fast scan cyclic voltammetry at carbon fiber microelectrodes to quantify short chain fatty acids in situ.

  2026cites this paper
• Lipid metabolism, remodelling and intercellular transfer in the CNS

  2025influential citation
• 1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production

  2025cites this paper
• The emerging role of microbiota derived SCFAs in neurodegenerative disorders

  2025influential citation
• Fusobacterium nucleatum enhances amphetamine-induced behavioral responses through a butyrate-driven epigenetic mechanism.

  2025cites this paper
• Microbiome functional gene pathways predict cognitive performance in older adults with Alzheimer’s disease

  2025cites this paper
• Neurosteroids, Microbiota, and Neuroinflammation: Mechanistic Insights and Therapeutic Perspectives

  2025cites this paper
• The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis

  2025cites this paper
• Associations of diet-derived short chain fatty acids with Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Exploring the microbiota-gut-brain axis: impact on brain structure and function

  2025cites this paper
• Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson’s disease: Innovative therapies and their translation

  2025cites this paper
• Fusobacterium nucleatum determines the expression of amphetamine-induced behavioral responses through an epigenetic phenomenon

  2025cites this paper
• Short-Chain Fatty Acid Profiles in Amyotrophic Lateral Sclerosis: Longitudinal Effects of Disease and Mediterranean Diet Intervention

  2025cites this paper
• The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer’s disease

  2025cites this paper
• Advances in the role of cGAS-STING pathway on the repair of central nervous system injury based on gut microbiota.

  2025cites this paper
• Dietary Supplementation of Edible Mushroom Phallus atrovolvatus Aqueous Extract Attenuates Brain Changes in the AppNL−G−F Mouse Model of Alzheimer’s Disease

  2025cites this paper
• Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease

  2025cites this paper
• Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications

  2024cites this paper
• Relationship Between Autism Spectrum Disorder And The Brain-Gut Axis

  2024cites this paper
• The role of gut-derived short-chain fatty acids in Parkinson's disease

  2024cites this paper
• Microglia and Gut Microbiota: A Double-Edged Sword in Alzheimer's Disease.

  2024cites this paper
• Alterations in gut microbiota contribute to cognitive deficits induced by chronic infection of Toxoplasma gondii.

  2024cites this paper
• Gut microbiota modulates depressive-like behaviors induced by chronic ethanol exposure through short-chain fatty acids

  2024cites this paper
• Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation

  2024cites this paper
• Colonic butyrate administration modulates fear memory but not the acute stress response in men: A randomized, triple-blind, placebo-controlled trial.

  2024cites this paper
• Exploring environmental exposomes and the gut-brain nexus: Unveiling the impact of pesticide exposure.

  2024cites this paper
• Microbiota–gut–brain axis: the mediator of exercise and brain health

  2024cites this paper
• Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?

  2024cites this paper
• Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis

  2024cites this paper
• Oral Administration of Bifidobacterium lactis Ameliorates Cognitive Deficits in Mice Intracerebroventricularly Administered Amyloid Beta via Regulation the Activation of Mitogen-activated Protein Kinases

  2024cites this paper
• COVID-19-associated encephalopathy: connection between neuroinflammation and microbiota-gut-brain axis

  2024cites this paper
• The Role of Macronutrients and Gut Microbiota in Neuroinflammation Post-Traumatic Brain Injury: A Narrative Review

  2024cites this paper
• The Postbiotic Properties of Butyrate in the Modulation of the Gut Microbiota: The Potential of Its Combination with Polyphenols and Dietary Fibers

  2024cites this paper
• Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study

  2024cites this paper
• Metabolic preferences of astrocytes: Functional metabolic mapping reveals butyrate outcompetes acetate

  2024cites this paper
• Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction

  2024cites this paper
• Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges

  2023cites this paper
• Peripheral Regulation of Central Brain-Derived Neurotrophic Factor Expression through the Vagus Nerve

  2023cites this paper
• Microbial Reprogramming in Obsessive–Compulsive Disorders: A Review of Gut–Brain Communication and Emerging Evidence

  2023cites this paper
• Salts of short-chain fatty acids increase the activity of the large conductance, Ca2+-activated K+ channels and reduce calcium oscillations in rat GH3 cells

  2023cites this paper
• History and function of the lactate receptor GPR81/HCAR1 in the brain: a putative therapeutic target for the treatment of cerebral ischemia.

  2023cites this paper
• Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic

  2023cites this paper
• Boundaries and integration between microbiota, the nervous system, and immunity.

  2023cites this paper
• The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.

  2023cites this paper
• Epigenetic effects of short-chain fatty acids from the large intestine on host cells

  2023cites this paper
• Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models

  2023influential citation
• Automated production of [11C]butyrate for keto body PET imaging.

  2023cites this paper
• Gut microbiota-derived short chain fatty acids act as mediators of the gut–brain axis targeting age-related neurodegenerative disorders: a narrative review

  2023cites this paper
• Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids

  2023cites this paper
• Short chain fatty acids: the messengers from down below

  2023cites this paper
• The microbiota-gut-brain axis in hippocampus-dependent learning and memory: current state and future challenges.

  2023cites this paper
• Gut microbial regulation of innate and adaptive immunity after traumatic brain injury

  2023cites this paper
• Salts of Short-Chain Fatty Acids Increase the Activity of Large Conductance Ca2+-Activated K+ Channels and Decrease Calcium Oscillations in Rat GH3 Cells

  2023cites this paper
• Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease

  2022cites this paper
• Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review

  2022cites this paper
• Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge

  2022cites this paper
• Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.

  2022cites this paper
• A novel set of volatile urinary biomarkers for late-life major depressive and anxiety disorders upon the progression of frailty: a pilot study

  2022cites this paper
• Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms

  2022cites this paper
• Gut microbiota-derived metabolites and their importance in neurological disorders

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.

  2022cites this paper
• The role of nutrition in canine idiopathic epilepsy management: Fact or fiction?

  2022cites this paper
• Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain

  2022cites this paper
• Prevention of Neurologic Disease with Fasting

  2022cites this paper
• Short-chain fatty acids profiling in biological samples from a mouse model of Sjögren's syndrome based on derivatized LC-MS/MS assay.

  2022cites this paper
• Ischemic stroke and intestinal flora: an insight into brain–gut axis

  2022cites this paper
• The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature

  2022cites this paper
• Applications of Medium-Chain Triglycerides in Foods

  2022cites this paper
• How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation

  2022cites this paper
• Short-Chain Fatty Acids-A Healthy Bus between Gut Microbiota and Organs beyond the Gut

  2022cites this paper
• Acute and chronic effects of oral administration of a medium‐chain fatty acid, capric acid, on locomotor activity and anxiety‐like and depression‐related behaviors in adult male C57BL/6J mice

  2022cites this paper
• Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease

  2022cites this paper
• Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins.

  2022cites this paper
• Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

  2022cites this paper
• Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials

  2022cites this paper
• Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson’s Disease

  2022cites this paper
• Short-Chain Fatty Acids Ameliorate Depressive-like Behaviors of High Fructose-Fed Mice by Rescuing Hippocampal Neurogenesis Decline and Blood–Brain Barrier Damage

  2022cites this paper
• mTOR/α-ketoglutarate-mediated signaling pathways in the context of brain neurodegeneration and neuroprotection.

  2022cites this paper
• The Blood–Brain Barrier, an Evolving Concept Based on Technological Advances and Cell–Cell Communications

  2021cites this paper
• Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.

  2021cites this paper
• Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites

  2021influential citation
• Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier

  2021cites this paper
• Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.

  2021cites this paper
• Butyrate in Energy Metabolism: There Is Still More to Learn.

  2021cites this paper
• Development and Validation of a LC-MS/MS Technique for the Analysis of Short Chain Fatty Acids in Tissues and Biological Fluids without Derivatisation Using Isotope Labelled Internal Standards

  2021cites this paper
• Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing–Remitting Multiple Sclerosis

  2021cites this paper
• Microbiota-gut-brain axis in autism spectrum disorder.

  2021cites this paper
• Metabolic regulation on the Immune Environment of Glioma through Gut Microbiota.

  2021cites this paper
• Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis

  2021cites this paper
• Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply

  2021cites this paper
• Neurodevelopment and the gut microbiome

  2020cites this paper
• Bioenergetic adaptations to HIV infection. Could modulation of energy substrate utilization improve brain health in people living with HIV-1?

  2020cites this paper
• Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review

  2020cites this paper
• The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms, and Approaches to Treatment.

  2020cites this paper
• The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

  2020cites this paper
• Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective

  2020cites this paper
• The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology

  2020cites this paper